Personally dedicated to customer success / Reimagining the future of stem cells
Responsible, respectful team, working and winning together
R. Lee Buckler, BEd, LLB
Lee is the VP of Business and Corporate Development for RepliCel Life Sciences, Inc. Prior, he was the founder and managing director of Cell Therapy Group – a leading, boutique consultancy focused on the cell therapy and regenerative medicine industry. Since early 2000, Lee has been an executive in the cell therapy regenerative medicine industry. He has significant experience in both for-profit companies and non-profit organizations including Progenitor Cell Therapy, Malachite Management, Stem Cell Technologies, and the International Society for Cellular Therapy. http://celltherapygroup.com/Buckler.html
Rob Carlson, PhD
Rob is interested in the future role of biology as a human technology and is a founder of Biodesic, a consulting firm at the juncture of biology and other disciplines such as marketing, engineering, and investment. He has worked to develop new biological technologies in both academic and commercial environments, focusing on molecular measurement and microfluidic systems. Carlson is the author of the book Biology is Technology: The Promise, Peril, and New Business of Engineering Life, published in 2010 by Harvard University Press. http://www.biodesic.com/People.html
Andras Forgacs, MBA
Andras is the co-founder of Modern Meadow as well as Organovo, which pioneered the use of 3D bio-printing to create human tissue for a range of medical applications. Prior to that, Andras was as Managing Director with Richmond Global, an international technology-focused venture fund, was a consultant in the New York office of McKinsey & Company focused on biopharma and private equity, and was a founding member of Citigroup’s corporate and investment banking e-commerce group. He is also co-founder and Chairman Emeritus of the international non-profit Resolution Project. http://modernmeadow.com/team/management/
Martin C. Peters, PhD
Martin C. Peters has over 12 years of professional experience developing and commercializing healthcare products from first-in-man through launch and life-cycle management. Martin is currently the Sr. Director of Program Leadership & Management at Biogen Idec and prior to this has served as Vice President of US Marketing for Novartis Vaccines, Sr. Director of Strategic Marketing for Aastrom Biosciences and as a Project Leader with the Boston Consulting Group. He holds a PhD from the University of Michigan where he was a Whitaker Foundation Fellow working on cell therapy for tissue engineering applications. He currently has six patents and over a dozen peer-reviewed articles covering cell therapy-related topics. LinkedIn Profile.
Prem Ramaswami, MBA
Prem has been a Product Manager at Google since 2006 and recently earned an MBA from the Harvard Business School, where he also served as a Teaching Fellow. At Google, Prem leads Google's health efforts in Google Search and Research. Prem has worked on projects such as Google Checkout, Google’s ecommerce shopping solution, and the Internet Bus Project aimed at increasing Internet penetration in India. Prem was also part of Google’s Network Infrastructure team as part of the Make the Web Faster Initiative launching Google Public DNS and started Google.org's Crisis Response Team. LinkedIn Profile.
Phil Vanek, PhD
Phil is General Manager of GE Healthcare’s Cell Bioprocessing business, a $6 billion strategy to revolutionize the world’s health by improving the quality, access and affordability of care. Phil joined GE from Lonza where he was Head of Innovation for Lonza’s Pharmaceutical division. Phil’s career has included a number of senior innovation, business and market development roles at Becton Dickinson, Invitrogen and Life Technologies, as well as two start-up biotechnology companies in the Washington, DC area. http://alliancerm.org/page/executive-committee-phil-vanek